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Abstract 
 
Despite remarkable advances in cure rates, childhood acute lymphoblastic leukemia 
(ALL) may continue to result in considerable family strain. We sought to 1) measure 
incidence of divorce, reduced career opportunities, changes to work hours, home 
relocation, and changes to family planning at one year after ALL diagnosis 2) identify 
family and patient factors associated with these events. We conducted a prospective 
cohort study of 159 children with average risk-ALL enrolled and treated on COG 
protocol AALL0331 at 31 selected sites. In the first year of ALL treatment, 46% of 
parents lost a job, 13% divorced/separated, 22% decided not to have more children, 51% 
declined occupational opportunities, 68% decreased work hours, and 27% of families 
relocated homes. In adjusted analyses, no unifying factors were associated with all family 
events. Relocation correlated with less maternal education (OR: 4.27 [95% CI: 1.43-
12.82]). Declining parental opportunities associated with family income <$50,000 (OR: 
4.25 [95% CI: 1.50-12.02]) and child <5 years old (OR: 4.21 [95% CI: 1.73-10.25]). 
Deciding not to have more children correlated with smaller family size 2-3 vs.4-5 (OR: 
3.62 [95% CI: 1.10-11.96]). In summary, childhood ALL still confers a substantial family 
burden, especially in the earlier stages of treatment.  
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Introduction 
Currently, over ninety percent of children diagnosed with standard-risk acute 
lymphoblastic leukemia become long-term survivors. In a study utilizing multiple 
Children’s Oncology Group national leukemia trials over a few decades, Hunger et al. 
found improved survival among all age, gender, racial, and disease risk stratification 
subgroups, excluding infants less than or equal to one years old (1). This study 
encompassed more than fifty percent of estimated cases of acute lymphoblastic leukemia 
in children and young adults in the United States. Compared to the five-year survival rate 
of 83.7% in the early 1990s, the survival rate in the early 2000s was reported as 90.4%. 
Improved survival was attributed to decreased incidence of death secondary to relapse or 
progression of leukemia. Hunger credited enhanced treatment regimens based on patient-
specific genotype and molecular targets, such as inclusion of imatinib for patients with 
Philadelphia chromosome positive acute lymphoblastic leukemia, with the overall 
increased rate of survival.  
However, even with high cure rates, the cancer experience can be overwhelming. 
The duration of therapy for standard-risk leukemia is two to three years, involving 
frequent clinic visits, unanticipated hospitalizations, and other therapy-related 
complications. Children suffer fatigue, nausea, prolonged absence from school, and 
behavioral changes as side effects of chemotherapy.  
The challenging experience of cancer has psychological repercussions for the 
family. At the Children’s Hospital of Philadelphia, Kazak et al. studied posttraumatic 
stress in one hundred and twenty-five families of children diagnosed with a pediatric 
cancer, most of whom were diagnosed with leukemia. Based on the Posttraumatic Stress 
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Disorder Reaction Index self-report survey, the majority of parents (68% of mothers and 
57% of fathers) scored in the moderate to severe range for posttraumatic stress symptoms 
during active treatment. Similarly, a prior study by Kazak et al. found more posttraumatic 
stress symptoms in parents of childhood leukemia survivors than in parents of healthy 
children, though these symptoms manifested to a lesser degree in parents of survivors 
than in parents with children actively undergoing treatment (2,3). 
In addition to the psychological stresses, families experience many financial, 
social, and family-management burdens, which have not yet been well-quantified. Prior 
studies on the family burden of pediatric cancer tend to be qualitative and measure broad 
domains of family stress. For example, Patterson et al. utilized focus groups of parents of 
childhood cancer survivors to assess family strain. Twenty-six families were represented 
in total, and their recorded responses were transcribed and categorized into various 
domains of relational or financial strain. Instead of quantifying specific, discrete family 
life events, Patterson reported such outcomes as “Strong parental emotions during 
treatment (feeling numb, devastated, overwhelmed; helpless, loss of control; fear child 
would die; grief re pain, losses; guilt)” or “Parent-child relationship strains (being 
overprotective of child; uncertainty re child’s independence; telling child diagnosis; 
conflict over taking meds)” (4). 
Studies of family burden, specifically in childhood acute lymphoblastic leukemia, 
are limited. Instead, past studies used cohorts that included patients with heterogeneous 
cancers that varied in therapy intensity, hospitalization rates, and need for radiation 
therapy. The impact on the family may have differed based on the type of malignancy. 
Certain cancers, such as central nervous system or bone malignancies, are associated with 
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more severe symptom manifestations and intensive treatment regimens. These studies 
were also performed in earlier treatment eras, relied on retrospective data, and yielded 
conflicting results (2-4).  
With respect to childhood cancer’s impact on parental marriages, past studies 
found differing results, showing both increased and decreased divorce/separation rates 
compared to population norms. In a national registry-based study in Denmark, Grant et 
al. compared the risk of termination of parental cohabitation between parents of two 
thousand four hundred and fifty children with cancer and parents of forty-four thousand 
eight hundred and fifty-three age and gender matched controls. Of the cohort of children 
with cancer, nine hundred and eighteen were diagnosed with leukemia or lymphoma. 
Grant assessed cohabitation, rather than formal marriage, to reflect modern family 
structures since 60% of first-born children in Denmark are born to cohabitating, non-
married parents. Utilizing the substantial registry data, Grant et al. were able to assess the 
state of certain families up to twenty years post-cancer diagnosis. They found no 
association between a child’s cancer diagnosis and parental separation with similar risk of 
dissolution of cohabitation in both the study and control cohorts. Furthermore, parents of 
children who survived a cancer diagnosis did not have significantly different rates of 
separation than parents of children who did not survive. In both the study and control 
groups, factors that associated with increased risk of parental separation included low 
family income, unemployment, young parental age, living in more urban settings, and 
increased length of time since entry into the study (5).  
Grant’s results were similar to an earlier national registry-based study in the 
Netherlands by Syse et al. Syse compared four thousand five hundred and ninety married 
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couples with a child with cancer and over nine hundred and seventy thousand married 
couples with a child without cancer. Syse found no association between a child’s cancer 
diagnosis and increased risk of parental divorce. Time since diagnosis, child’s age, and 
survival also did not significantly affect divorce rates. Interestingly, Syse found that 
maternal education greater than high school level correlated with increased rates of 
divorce in parents of children with cancer. The authors noted that, in Norway, shared 
parental responsibility after separation occurs more commonly when mothers have 
attained higher education. However, they were unable to conclude whether this fact 
contributed to the increase in divorce rates amongst higher maternal education parents of 
children with cancer in their study (6).  
In contrast to these two large population studies, in 1976, Kaplan et al. found 
increased rates of divorce/separation (23%) three months after the death of a child with 
leukemia (7). It is important to note that the survival rate in the 1970s is not reflective of 
current therapy and that Kaplan’s use of a population that suffers such extreme emotional 
distress, such as loss of a child, may not accurately portray the experience of the majority 
of parents of current children diagnosed with leukemia.   
Like past studies regarding childhood cancer’s impact on parental marriage, 
available studies concerning changes in parental employment showed mixed results, were 
limited in their sample size and distribution, and/or were performed in former treatment 
eras (8-13). Available studies concerning changes in parental employment in the United 
States are over two decades old (8-10). In the early 1980s, Bloom et al. studied five 
hundred and sixty-nine children with cancer and the medical costs of treatment, out-of-
pocket disease-related costs, and loss of parental wages to their families. Of the children 
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in Bloom’s study, slightly less than 30% were diagnosed with acute lymphoblastic 
leukemia. Bloom found families spent an average of 38% of gross annual income on 
disease-related care, which encompassed medical expenses (hospitalizations, 
medications, physicians, etc.), nonmedical, but disease-related, expenses (transportation 
to and from the hospital, costs for child home services, etc.), and indirect expenses such 
as lost parental wages. Lost wages accounted for a large proportion of the costs (8). 
Bloom noted that costs were particularly high in the first year of diagnosis and tapered 
off as treatment progressed; costs rose again if a child did not respond well to treatment. 
Two earlier studies by Lansky et al. likewise attempted to quantify medical and 
non-medical costs to families of children with cancer (9,14). Lansky qualified 
nonmedical costs as expenses related to transportation to and from treatment sites, 
lodging for out-of-town patients and their families, meals, and family care. For non-
medical expenses, seventy families with children undergoing treatment for cancer at the 
University of Kansas Medical Center completed weekly expense journals. A subgroup of 
parents also completed a log regarding loss of wages. About half of the families sampled 
reported loss of pay. Like Bloom, Lansky noted that the bulk of costs were bimodal in 
distribution, peaking at the earlier stages of treatment as well as terminal stages.  
Researchers in countries with public health insurance have published more recent 
studies regarding pediatric cancer and financial burden (11-13). A Canadian pilot study in 
British Columbia in the 1990s evaluated child’s cancer diagnosis’s financial impact on 
the family. In this study, Limburg et al. used a retrospective questionnaire to sample over 
one hundred patients and their families to assess how parental employment was affected 
by a child’s cancer diagnosis and what, if any, alternative sources of income were 
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utilized. This cohort included heterogeneous cancers with less than a quarter of patients 
diagnosed with leukemia. Children had to be at least two years post-diagnosis to facilitate 
capturing changes to parental employment over the entire treatment course. Limburg 
concluded that most families suffered considerable, albeit short-term, economic losses 
during their child’s cancer treatment (12). Limburg conceded that this conclusion may 
not be generalizable to countries with different health insurance policies. For example, in 
the United States, private health insurance predominates, and coverage of children is 
often tied to their parents’ employment. The need to maintain health insurance coverage 
may limit a parent’s ability to take extended leave from work. Furthermore, the results of 
Limburg’s study may suffer from selection bias, as the final response rate was merely 
41%. Families who were unable or unwilling to return questionnaires may be the families 
with less financial resources or less employment stability.  
In a larger Norwegian population-based study by Syse et al., a child’s cancer 
diagnosis was not associated with parental loss of employment. Syse utilized national 
census data to compare parents of over three thousand children with cancer with parents 
of healthy children. When analyzed by particularly type of cancer, there was no 
significant association between type of cancer and loss of parental employment. Contrary 
to the expectation of increased family management strains associated with more children, 
no association between loss of employment and increased family size was found. 
However, younger age of child at diagnosis (less than 10 years old) was associated with 
about a ten percent decrease in maternal earnings. Interestingly, in families of children 
diagnosed with cancer, lower maternal education correlated with decreased cessation of 
employment (OR 1.31) (13).  
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In contrast, Heath et al. reported great financial hardship among families newly 
diagnosed with childhood cancer in 2002 in Australia (15). Heath analyzed self-report 
questionnaires regarding economic burden from fifty-six parents of children newly 
diagnosed with cancer. Of families studied, greater than seventy percent of parents 
reported great or moderate financial hardship after their child’s diagnosis. Financial 
hardship included disruption of employment, loss of income, use of sick leave and other 
employee benefits, and costs of relocation to areas closer to treatment centers. Families 
who experienced greater economic burden had lower household income, lived a greater 
distance from the treatment center, and were single-parent households. Over ninety 
percent of parents reported that these economic difficulties greatly added to their 
emotional distress, and sixty percent of couples reported that these financial burdens 
negatively affected their spousal relations to a large degree. These findings are surprising 
given the availability of government funds for assisting families with children with 
cancer in Australia. Heath et al. report that, given public health insurance, the out-of-
pocket costs paid by a family of a child undergoing cancer treatment in Australia is 
roughly half the total cost in the United States. The authors conclude that available 
resources are not being delivered effectively to families with the greatest need since 
families not in the lowest income bracket, who also did not self-report financial need, 
also received financial assistance. 
Despite the range of studies completed in geographically and temporally varied 
settings and the use of assorted research methodologies, at present, there are no studies 
regarding objective family life events, after a childhood acute lymphoblastic leukemia 
diagnosis, in an ethnically diverse patient population, in the modern era of therapy. 
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Measuring the family burden of average risk B-precursor acute lymphoblastic leukemia 
and its treatment is particularly important because it is among the most common and 
curable of childhood cancers (1). Pediatric cancer centers already recognize the need for 
multidisciplinary, family-centered care that encompasses the psychosocial needs of the 
family. The well-being of the family unit has repercussions for the child’s health. As 
noted by Patterson et al., past studies note a bidirectional effect between parental 
psychological well-being and psychosocial difficulties in survivors of childhood cancer. 
This includes posttraumatic stress disorder symptoms in survivors of childhood cancer 
whose parents suffered posttraumatic stress disorder symptoms (4). Positive parental 
responses had a protective effect on children during their cancer treatment (16). 
Prospective and representative data, in the current era of therapy, regarding critical family 
outcomes are needed to inform further support interventions and to empower healthcare 
providers to offer anticipatory guidance to families.  
In this prospective, longitudinal study, our aim was to measure the relational, 
financial, and psychosocial burdens to families of children treated for newly diagnosed 
average risk acute lymphoblastic leukemia. We hypothesized that, despite advances in 
treatment, a childhood diagnosis of acute lymphoblastic leukemia still placed a 
significant burden to families in the form of an increased incidence of adverse family life 
events. We recruited patients enrolled on Children’s Oncology Group therapeutic 
protocol AALL0331 from a predominantly United States subset of all Children’s 
Oncology Group clinical trials sites. We selected patients with average risk features as 
this risk stratification group represents the majority of pediatric acute lymphoblastic 
leukemia. Families were surveyed regarding the incidence of discrete family life events at 
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three time points during the first year of therapy. We sought to 1) measure the incidence 
of changes in marital status, parental occupational and educational opportunities, parental 
work hours, location of home, and family planning and 2) identify family and patient 
factors associated with a greater likelihood of these major family life events. 
 
Methods 
Study population 
We conducted a prospective, longitudinal study of major life events in families of 
children with average risk acute lymphoblastic leukemia who were enrolled and treated 
on Children’s Oncology Group protocol AALL0331 between April 2005 and March 2009 
at thirty-one sites (thirty American sites and one Australian site) selected from 
approximately two hundred sites at which this trial was open to patient enrollment. 
Participating institutions were selected to represent a broad geographic distribution and 
both community care and tertiary care centers. The thirty-one sites are as follows: 
Children’s Hospital Medical Center (Akron, OH), Children’s Hospital at the Cleveland 
Clinic (Cleveland, OH), Children’s Hospital Colorado (Aurora, CO), Children’s Hospital 
of Central California (Madera, CA), Children’s Hospital and Clinics of Minnesota 
(Minneapolis and St. Paul, MN), Children’s Hospital (New Orleans, LA), Children’s 
Hospital of Pittsburgh (Pittsburgh, PA), Seattle Children’s Hospital (Seattle, WA), Helen 
DeVos Children’s Hospital (Grand Rapids, MI), Doernbecher Children’s Hospital 
(Portland, OR), Nemours/Alfred I. DuPont Hospital for Children (Wilmington, DE), East 
Tennessee Children’s Hospital (Knoxville, TN), Hackensack University Medical Center 
(Hackensack, NJ), Randall Children’s Hospital at Legacy Emanuel (Portland, OR), Loma 
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Linda University Medical Center (Loma Linda, CA), Midwest Children’s Cancer Center 
(Milwaukee, WI), Nevada Cancer Research Foundation, Princess Margaret Hospital for 
Children (Perth, Australia), St. Vincent Hospital Regional Cancer Center (Green Bay, 
WI), Packard Children’s Hospital at Stanford (Stanford, CA), SUNY Upstate Medical 
University (Syracuse, NY), St. Joseph’s Children’s Hospital of Tampa (Tampa, FL), 
University of Alabama at Birmingham Hospital (Birmingham, AL), University of Florida 
Academic Health Center (Gainesville, FL), University of Minnesota Medical Center, 
Fairview (Minneapolis, MN), Children’s Hospital University of Mississippi Medical 
Center (Jackson, Mississippi), University of New Mexico Children’s Hospital 
(Albuquerque, New Mexico), University of Texas Southwestern Medical Center (Dallas, 
TX), American Family Children’s Hospital University of Wisconsin Children’s Hospital 
(Madison, WI), Children’s Hospital at Vanderbilt (Nashville, TN). Additional eligibility 
criteria included age ≥2 years old at diagnosis and at least one parent with English or 
Spanish literacy, the languages for which validated surveys were available. Average risk 
acute lymphoblastic leukemia is defined as standard risk acute lymphoblastic leukemia 
by National Cancer Institute criteria (peripheral white blood count <50,000 and age 
between 1.0 and 9.99 years) (17) with no central nervous system or testicular leukemia, 
and bone marrow minimal residual disease <0.1%  at the end of four weeks of Induction 
therapy. Patients with Down syndrome and/or certain molecular features such as 
favorable cytogenetics (trisomies of 4, 10, and 17 or TEL-AML translocation) were also 
eligible for enrollment in this trial. Patients with prior steroid therapy were eligible for 
enrollment while patients with prior cytotoxic chemotherapy exposure, excepting 
intrathecal cytarabine, were excluded. Patients who relapsed during the duration of the 
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trial were also excluded. (See http://www.cancer.gov/clinicaltrials/search/view? 
cdrid=409589&version=HealthProfessional  for more details). 
At the end of Induction therapy, average risk acute lymphoblastic leukemia 
patients who consented to continue on the AALL0331 trial were randomized in a 2x2 
therapeutic trial design to: 1) standard Consolidation (SC) vs. intensified Consolidation 
(IC) therapy that added two doses of cyclophosphamide and peg-asparaginase and 2) 
standard Interim Maintenance (SIM) with oral methotrexate vs. augmented Interim 
Maintenance (AIM) with escalating intravenous (IV) methotrexate as post-Consolidation 
therapy. Maturation of protocol CCG-1991 data showed that IV methotrexate was 
superior to oral methotrexate (18). Therefore, all patients enrolled subsequent to 
09/29/2008 received IV methotrexate, and the study randomization regarding post-
Consolidation was closed.     
Of the patients enrolled in AALL0331 at the thirty-one participating institutions, 
194 patients met the eligibility criteria for this health-related quality of life ancillary 
study. Of these, twenty-four declined participation. Of the one hundred and seventy who 
consented, four patients withdrew prior to administration of the first set of surveys, and 
seven did not receive the first set of evaluations due to administrative errors. The thirty-
five eligible non-participants were similar to the one hundred and fifty-nine patients who 
participated (82% of eligible) with regards to gender and age at diagnosis.  Participants, 
compared to non-participants, were more likely to be White (p=0.01). Compared to the 
greater therapeutic AALL0331 study population, participants were similar with regards to 
gender distribution, but more likely to be ≥ 5 years old at diagnosis, White, and 
randomized to Standard (not Augmented) Interim Maintenance (Table 1).  
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Based on a 7.4% divorce rate nationally (per 2011 maternal age-matched census 
data), which results in an expected proportion of approximately 0.10,  and a 95% 
confidence interval with a total width of confidence interval of 0.10, our study would 
require a sample size of 138 (Appendix 6E of Designing Clinical Research (19)). As 
such, our study was sufficiently powered with a sample size of 159. 
Procedures 
In addition to the Yale University Human Investigation Committee, institutional 
review boards of each participating center approved the current study. Informed consent 
and assent, when indicated, were obtained for all participants. Each participating family 
in the study was assigned a Children’s Oncology Group participant code to protect 
patient privacy and comply with Health Insurance Portability and Accountability Act 
standards.  
The self-identified primary caregiver (the child’s mother in 84% of instances) 
completed surveys during regular clinic visits at three selected time points within the first 
year of therapy: day 1 of Consolidation phase (~1 month after diagnosis), end of Delayed 
Intensification phase (~6 months after diagnosis), and six months after starting 
Maintenance phase (~12 months after diagnosis).  
Measures 
Socioeconomic data were obtained using a parent demographic survey, which 
included questions about race/ethnicity, household income, marital status, maternal 
education, and family size. In this study, marital status responses of “married” or “living 
with someone in a marriage-like relationship” were consolidated due to their presumed 
similar impact on social and financial support and to reflect current family structures.  
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Incidence of major family life events was quantified by line item responses to the 
Family Inventory of Life Events and Changes Subset (FILE-S; adapted from McCubbin, 
Patterson, and Wilson 1991 (20)). Parents were specifically asked whether the following 
life events occurred since their child’s diagnosis of leukemia. For changes in marital 
status, “Husband and wife separated or divorced.” For increased work hours, “Took a 
second job or worked more hours.” For decreased work hours, “Quit or lost my job.” or 
“Worked part-time instead of full-time.” For decreased occupational/educational 
opportunities, “Did not start a job but wanted to.” “Did not accept a job promotion or 
transfer.” or “Quit or did not start further education/training.” For change in residence, 
“Moved to different home or community.” For changes to family planning, “Changed 
plan and decided not to have more children.”  
Family coping was assessed using the Coping Health Inventory for Parents (21), 
which has been validated for children with a variety of chronic illnesses. In this forty-
five-item checklist, parents rate how helpful a particular coping behavior is (e.g. “talking 
over personal feelings and concerns with spouse” and “talking with other parents in the 
same type of situation and learning about their experiences”) on a four point scale 
ranging from “not helpful” to “extremely helpful”. Responses to these questions are then 
consolidated to determine scores for three subscales of coping behaviors. The three 
subscales, (1) Maintaining family integration and optimism, (2) Maintaining social 
support and self-esteem, and (3) Understanding the medical situation, have  reliabilities 
of 0.79, 0.79, and 0.71. A higher score on each subscale indicates a greater reliance on 
that coping pattern, but there are no normative scores.  
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Parental perception of cancer’s impact on a child’s quality of life was measured 
using the PedsQL 3.0 Cancer Module Parent Proxy-Report (22). In this twenty-seven-
item questionnaire, parents rate each item on a five point scale ranging from “never a 
problem” to “almost always a problem”. Of the eight subscales, “Nausea” ( reliability of 
0.85) and “Pain and Hurt” ( reliability of 0.89) subscales were analyzed as these 
physical symptoms are typical acute lymphoblastic leukemia treatment complications. A 
higher score indicates fewer problems or symptoms. 
Data analyses 
The family and patient factors of age at diagnosis, gender, and race/ethnicity were 
summarized and compared between participants and eligible nonparticipants using an 
exact chi-square test to evaluate the potential for response bias. Data regarding eligible 
nonparticipants were obtained from the AALL0331 therapeutic study database.  
The primary outcomes of interest were changes in marital status, parental working 
hours, parental work and educational opportunities, moving of residence, and family 
planning at the three time points after diagnosis. The cumulative incidences of loss of 
employment, home relocation, and divorce/separation among married couples at one year 
after diagnosis were calculated after excluding the eight Australian participants to enable 
comparison with available United States Census data. However, the data from the eight 
Australian participants were included in the final logistic regression analyses. Logistic 
regression was used for univariate and multivariate analyses for each outcome. Potential 
predictors that were nominally significant at p value of <0.1 in the univariate analyses 
were included in the multivariate model. In addition, we determined, based on the 
longitudinal model with repeated measures, whether the incidence of events changed 
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significantly between the three time points. All analyses were performed using SAS® 
software, Version 9.2 (SAS Institute Inc., Cary, NC, USA; 2008).  
Samantha Lau composed the analysis plan to determine the impact to families of a 
new diagnosis of standard risk acute lymphoblastic leukemia in children, corresponded 
with site-based clinical research associates to facilitate timely collection of data, coded 
and entered collected data into a central system, conceptualized the data analysis, 
interpreted the data results, and wrote this manuscript. Regina Myers and Moira Whitley 
entered data and communicated with site investigators to coordinate timely data 
collection. Xiaomin Lu, PhD. and Meenakshi Devidas, PhD. carried out completed data 
analysis and advised on best methods of analysis given the research aims and available 
data. Lyn Balsamo, PhD., Naomi Winick, MD., Stephen Hunger, MD., Linda Stork, 
MD., Kelly Maloney, MD., and William Carroll, MD. interpreted the data results and 
provided suggestions for revisions upon reviewing the completed manuscript. Nina 
Kadan-Lottick, MD., MSPH designed the original ancillary study as part of the greater 
Children’s Oncology Group therapeutic trial, successfully applied for  NCI research 
funding, helped to formulate the aims, hypotheses, and study analysis plan, interpreted 
the data results, and reviewed and revised the manuscript.  
 
Results 
Characteristics of study population 
Table 1 displays characteristics of the one hundred and fifty-nine enrolled patients 
and their families. The study population was mostly White (68%) with 16% Hispanic and 
7% Black. The majority of parents were married or living in a marriage-like relationship 
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(75%) at the time of diagnosis. The majority of families consisted of four to five 
individuals (59%). The average maternal age at diagnosis was 34 years old with the 
majority of mothers achieving less than a college education (58%).  
Cumulative incidence of major family life events 
Table 2 displays the cumulative incidence of major family life events in the first 
year after diagnosis. Among the one hundred and twenty sets of parents initially married 
or living together in a marriage-like relationship, 13% divorced or separated by 
approximately twelve months after acute lymphoblastic leukemia diagnosis. Of those 
married, 10% divorced or separated (vs. 7.4% annually for married women 20-34 years 
old from the 2011 U.S. Census American Community Survey (23)). The incidence of 
moving to a different home was somewhat higher (27% vs. 21% annually) when 
compared to a group matched for average age of child at diagnosis (persons 1-4 years old 
from 2009 Census data (24)). After their child’s acute lymphoblastic leukemia diagnosis, 
22% of parents changed their plans and decided not to have additional children. 
Overall, the economic and occupational impact on families was substantial. 
Among parents, 51% declined work or educational opportunities, 18% increased work 
hours, and 68% decreased work hours (including 46% who reported loss of employment 
vs. 9.1% from 2010 Census data (25,26)). As seen in Figure 1, the increase in frequency 
of major family life events is greatest earlier in treatment but continues to steadily rise. 
This is most notable in outcomes involving parental employment. Forty-two percent of 
parents decreased work hours from the time of diagnosis to time point 1; at subsequent 
time points, the additional number of parents decreasing work hours was substantially 
less. The increases in frequencies of outcomes between time points are statistically 
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significant for all events at a significance level of p<0.05, except for the change in 
frequencies from time point 2 to 3 for divorce/separation, increased work hours, and 
decreased work hours.  
Patient and family factors associated with major family life events 
Table 3 displays the univariate analysis of factors associated with major family 
life events. Moving was strongly associated with maternal education less than college 
(OR=4.63, p=0.004) and non-White race/ethnicity (OR=2.88, p=0.008). Deciding not to 
have more children was associated with smaller family size (two to three vs. four to five 
members; OR=3.44, p=0.02). Declining occupational or educational opportunities was 
associated with lower family income (OR=3.21, p=0.003), child younger than 5 years at 
diagnosis (OR=2.48, p=0.008), and less than a college level education in the mother 
(OR=2.05, p=0.05). Less maternal education was also associated with divorce/separation 
(OR=4.61, p=0.05). A decrease in work hours was predicted by more intensive treatment 
(IC/AIM vs. SC/SIM; OR= 3.75, p= 0.04). Parental perception of the child’s pain and 
nausea and endorsement of parental coping behaviors were generally not associated with 
the studied outcomes.  
In multivariate analysis (Table 4), moving was substantially associated with lower 
maternal education (OR=4.27, p=0.009) but no longer associated with race/ethnicity. The 
strong association between deciding not to have more children and smaller family size 
(two to three vs. four to five; OR=3.62, p=0.04) remained. Declining occupational or 
educational opportunities was still associated with lower family income (<$50,000; 
OR=4.25, p=0.006) and younger age of child at diagnosis (<5 years old; OR=4.21, 
p=0.002). Randomization to IV methotrexate significantly (p<0.05) reduced the 
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likelihood of parents having to increase work hours or decline work/educational 
opportunities (OR=0.18 and 0.25, respectively). No unifying patient or family factor 
correlated with all six studied major family life events. 
 
Discussion 
Our multi-site, prospective study of one hundred and fifty-nine children 
undergoing contemporary therapy for childhood average risk acute lymphoblastic 
leukemia demonstrates that families experience considerable psychosocial, economic, 
and relational stresses despite the high probability of cure and mostly outpatient 
chemotherapy. These findings are consistent with our a priori hypothesis. By one year 
after diagnosis, 46% of the 68% of parents who decreased work hours either quit or lost 
their jobs, 18% increased work hours, 51% declined educational/occupational 
opportunities, 27% relocated residences, and 22% changed their family planning 
regarding additional children. In addition, 13% of parents, who were initially married or 
living-as-married, divorced or separated. In general, families of all socioeconomic 
backgrounds were vulnerable to economic stresses, ranging from increases and 
reductions in work hours to quitting or losing a job. Parental perception of a child’s 
physical symptoms, such as pain and nausea, as well as parental coping behaviors were 
not associated with studied outcomes, though nausea did limit continued study 
participation. While the burden is considerable, no common patient or family factor was 
identified that increased the likelihood of all these major life events. 
This is the first study to quantify the family burden of newly diagnosed childhood 
acute lymphoblastic leukemia in a large, racially and regionally diverse sample in the era 
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of modern therapy. The substantial percentage of patients from previously 
underrepresented groups (16% Hispanic and 7% Black) and the thirty designated sites 
from across the United States enable fair representation of the diversity of children who 
develop average risk acute lymphoblastic leukemia. Our high participation rate of 82% 
also mitigates major selection bias, although there was some bias given the requirement 
of parental English or Spanish literacy. In contrast to prior studies that mainly used 
measures of parental strain, coping measures, or qualitative interviews (11,27-32) to 
measure family burden, our study measured distinct family life events. Furthermore, the 
prospective cohort design of this study decreases the likelihood of recall bias as 
compared to prior retrospective questionnaire-based studies (4,12). In addition, our use of 
three time points within the first year of diagnosis, allows the results to reflect short-term 
changes in employment. This is a strength of our study as previous research has shown 
that the steepest changes in parental employment occur within the first year (8,12,14).   
In this study, the incidence of divorce/separation in married parents of children 
with acute lymphoblastic leukemia in the first year after diagnosis was only slightly 
higher than the United States national annual rate for women of a similar age range (10% 
vs. 7.4%). It is difficult to determine to what degree the child’s acute lymphoblastic 
leukemia diagnosis had affected parental marriage as the baseline state of the parents’ 
marriage was not assessed. Even so, our results concur with previous studies, which 
likewise report no impact on divorce rates. In 1978, Lansky et al. (33) found a similar 
divorce rate among parents during their child’s cancer treatment and a control group of 
parents of children with hemophilia. Lansky’s study differed from ours in the use of a 
control group that also experiences a high family burden due to childhood disease, a 
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single region sample that only included patients in Kansas and Missouri, and an older 
treatment era.  
More recent population studies from Norway and Denmark likewise concluded no 
significant increase in divorce rates (5,6) amongst parents with a child diagnosed with 
cancer. Similar to the study in Denmark by Grant et al., our results did not show a 
correlation between higher maternal education and divorce although this association 
between maternal education and divorce was noted by Syse in Norway. A strength of 
both the Danish and Norwegian national registry-based studies is the enormous sample 
size and subsequent power of their studies. Furthermore, given detailed reporting of data 
in multiple government-run registries and linking of individuals across various databases 
by government-issued identification numbers, Syse and Grant were able to follow 
accurately the progression of both childhood cancer diagnosis and outcome and parental 
marital relationships over an extended period of time. Potential weaknesses of both these 
registry-based studies, when attempting to generalize their results to pediatric leukemia, 
are their inclusion of all types of cancer as well as their use of a broad timeframe. The 
selection of patients diagnosed with cancer in the 1970s through the early 2000s results in 
a mixed study population that experienced vastly different treatment regimens and 
outcomes based on the time of a child’s diagnosis. However, the results were adjusted for 
time since diagnosis, which should assist in delineating treatment eras, and showed 
insignificant differences in divorce rates between parents of children with and without 
cancer. Another potential weakness of these studies is the inability to evaluate potentially 
confounding factors that may contribute to a couple’s decision to divorce, such as 
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baseline satisfaction with the marriage prior to a child’s cancer diagnosis or whether a 
couple had considered divorce prior to their child’s illness.  
Our results, like those of Syse and Grant, contrast with the increased rate of 
divorce/separation in parents whose children died from cancer that was reported by 
Kaplan et al. in 1976 (7). This difference may be attributed to newer therapy regimens 
and the resultant improved five-year acute lymphoblastic leukemia survival rates above 
90%.  
While the literature supporting increased divorce rates following a child’s cancer 
diagnosis is sparse, other studies took a more subjective approach, measuring marital 
dissatisfaction and stress rather than divorce/separation. Past studies concur that the 
experience of childhood cancer possesses the potential to substantially impact the marital 
relationship, either in a positive or negative manner. For example, Patistea et al. utilized 
open-ended interviews to assess the self-reported impact of an initial diagnosis of 
childhood leukemia on the parental marital relationship in twenty-nine Greek couples. 
They found that over a third of parents felt their child’s diagnosis of leukemia caused 
significant marital strain, particularly with regards to communication, while over forty 
percent of parents actually reported that their marital relationship strengthened as a result 
of their child’s diagnosis (32).   
Likewise, a study of thirty-five Israeli couples by Lavee et al. showed that a 
child’s cancer diagnosis and treatment simultaneously strengthened and weakened certain 
aspects of the marital relationship. Over forty percent of parents reported decreased 
marital satisfaction, specifically with respect to sexual intimacy, while slightly less than 
thirty percent actually reported improved communication between spouses. Couples 
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reported decreased satisfaction with their marriage with lengthening time of a child’s 
illness (greater than four years). Lavee et al. noted that the retrospective nature of their 
study may have led to averaging of changes to the marital relationship contributing to a 
perceived minimal net change in the marriage at the time of completion of the 
questionnaires (34).  
In Finland, Lahteenmaki et al. studied twenty-one families in the first year after a 
child’s cancer diagnosis to determine subjectively the impact on parental wellness in 
social, occupational, and health domains. When compared to forty-six maternal 
education-matched controls, parents of children with cancer reported no statistically 
different levels of marital satisfaction. Lahteenmaki suggests that the short follow-up of 
one year may have contributed to the lack of change in quality of parental marriage (11). 
A review performed by da Silva et al. included fourteen articles published 
between 1997 and 2009 and sought to comprehensively assess the effects of a child’s 
diagnosis of cancer on marital relationships. Da Silva noted similar temporal trends 
across multiple studies showing initial negative changes in marital relationships at 
diagnosis, minimal changes at one year of diagnosis, improvement in spousal relations in 
the first two to three years of treatment, and a mix of deterioration and maintenance of 
marital relationships for extended child illness. Nine of the fourteen articles noted that 
difficulties in communication played an important role in marital stress, especially in 
families where parents were geographically separated due to child’s hospitalization or 
distance of treatment site from home (35). Factors contributing to marital distress include 
balancing care of other children, difficulties in communication between spouses, negative 
mood that subsequently limits a spouse’s ability to be emotionally supportive, limitations 
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to previous work or social life, and shifting of roles (6,35). While our study did not show 
increased divorce rates following a child’s cancer diagnosis, further research in this area 
is needed given the qualitative impact of a cancer diagnosis on the marital relationship 
and the importance of the family unit to a child’s experience of cancer.  
By one year after diagnosis, about 20% of parents had decided to change family 
planning and not to have more children. Our study concurs with a 1995 retrospective 
Netherlands study by Van Dongen-Melman et al (36) wherein 20% of parents decided 
not to have more children after a child’s leukemia diagnosis. Family planning is pertinent 
to families of children with average risk acute lymphoblastic leukemia since the peak age 
at diagnosis is approximately 4 years old. Many parents of young children may be in the 
midst of building their families. Our study found that smaller family size (two to three vs. 
four to five) was predictive of changing family planning. This association may reflect that 
larger families have completed family building or decided not to have more children prior 
to a child’s cancer diagnosis. However, interpretation of these results is limited by lack of 
knowledge of parental rationale for changes to family planning. Furthermore, family 
planning is a dynamic decision process and may change subsequent to completion of a 
child’s treatment.  
The economic impact of a child’s diagnosis of average risk acute lymphoblastic 
leukemia is likewise substantial during the first year of therapy: 68% of parents decreased 
work hours, 18% increased work hours, and 51% declined occupational/educational 
opportunities. From our study, in the first year of treatment, 46% of families reported that 
one or more parents resigned from or lost their jobs. This is over five times the national 
annual incidence of unemployment among previously employed individuals. Our data 
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also indicated that more than half of parents decreased work hours and that the economic 
impact was felt most acutely at the onset of treatment.  
Prior studies, using prospective family expense journals (8,9) and population data 
analysis, (13) similarly recognized the economic impact of a cancer diagnosis and its 
treatment on families, noting 25-60% decreases in weekly income. In the 1980’s, 
Bloom’s study quantified expenses over a six-month period utilizing hospital billing 
records to calculate medical costs. A subset of patients was selected to complete week-
long expense diaries to account for out-of-pocket, nonmedical expenses. While Bloom 
accounted for certain aspects of indirect expenses by including lost parental wages, he 
accedes that the indirect costs were likely underestimated. This study did not account for 
loss of employment, decreased work productivity, or opportunity costs, such as not 
accepting a promotion that may require a parent to relocate (8).  
Lansky et al. similarly had families complete expense diaries and found that 
medical costs contributed less to total expenses than non-medical costs. While medical 
costs consumed 5.8% of a family’s weekly budget, nonmedical costs used up 26% of the 
weekly budget. Lansky reported associations between increased family size, decreased 
patient functioning, and distance from the hospital with increased nonmedical costs. In 
addition to devouring a larger portion of a family’s weekly expenses, nonmedical costs 
may prove even more stressful as they lack a system of reimbursement and require 
immediate payment (9,14). 
In Limburg’s study in Canada, the majority of parents, 65% of mothers and 78% 
of fathers, took leave from work during the first year of their child’s treatment, and the 
majority of parents, 80% of mothers and 89% of fathers, were able to return to their prior 
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employment after their initial leave of absence. By diagnosis, mothers of children 
diagnosed with leukemia had the greatest loss of work at 92%. While on employment 
leave at the time of diagnosis, a third of families relied on both salary and non-salary 
sources of income (employment insurance, social assistance, and other forms of financial 
support), and over ten percent of families solely relied on non-salary sources of income. 
By the time of the survey, after the vast majority of parents had resumed employment, the 
percentages of families utilizing both salary and non-salary income decreased to 13% 
while families using non-salary income sources decreased to 7%. Limburg concluded that 
a child’s cancer diagnosis induced a considerable, yet short-lived, loss of parental 
employment and shift in sources of family income (12).  
In the Norwegian study by Syse et al., parental loss of employment did not 
associate with a child’s cancer diagnosis. However, as noted in both national registry-
based publications by Syse et al., studies done in social welfare states where public health 
care is provided to all citizens free of charge may not be generalizable to other countries 
(6,13). Therefore, their finding no association between a child’s cancer diagnosis and loss 
of parental employment may only be applicable to other countries with similar welfare 
options such as Canada and certain Western European countries. Furthermore, this study 
by Syse et al., like their registry-based study on parental marriage, once again 
encompassed patients diagnosed over more than a decade. Syse noted some inconclusive 
variations in parental employment and earnings by time period that were not discussed 
further. It is possible that these variations were secondary to national economic shifts or 
adjustments in intensity of treatment regimens over time. In addition, the use of census 
data provides only one time point per year. As such, a potential limitation is the inability 
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to assess short-term employment changes within the first year of diagnosis. This is 
particularly noteworthy because previous studies have found most parental employment 
changes occur within that initial year of treatment (8,12,14). Strengths of this study 
include its large sample size as well as the use of government-collected census data, 
which minimizes the recall bias inherent to questionnaire-based studies.  
While other studies noted that parental losses of income had a more short-lived 
effect on a family’s financial well-being, this may not be the case in our studies as 
government-funded resources are more limited in the United States. As such, these results 
warrant further follow-up in the later stages of treatment to determine whether parents are 
as readily able to return to work or find alternative sources of income. Our results showed 
lower age of child (age <5) at diagnosis and lower family income (<$50,000) were 
associated with decreased occupational/educational opportunities. These associations 
may reflect the greater amount of supervision required for younger children and the 
greater burden of unexpected medical costs to lower income families. Families with 
lower income may have less money in savings, which limits their abilities to pay for extra 
expenses, such as a parent returning to college, when faced with the unexpected expense 
of a child’s illness. Furthermore, as noted by Syse (13), parents may be unable to take 
leave from work as lower paying jobs tend to be less flexible with regards to re-hiring 
employees after extended absences. Families with lower income likewise may be more 
dependent on a parent’s current employment, which forces a parent to maintain his or her 
job rather than explore other occupational or educational opportunities that may have less 
immediate financial security. 
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Intravenous methotrexate, compared to oral methotrexate, was associated with a 
lower likelihood of parents declining work/educational opportunities or increasing work 
hours. This may be due to possible differences in toxicities between the treatment arms. 
From a the CCG 1991 trial in which there was also an oral vs. escalating IV methotrexate 
randomization, more hepatic toxicity was observed in the oral methotrexate arm (18). 
This was attributed to the combination of the oral methotrexate with 6-mercaptopurine. In 
that study, patients on the oral methotrexate arms that immediately preceded the delayed 
intensification phases of therapy also had a higher number of mean hospital days during 
the delayed intensification. Toxicity outcomes have not yet been reported for the 
therapeutic arm of the current study (AALL0331) so we cannot confirm if toxicity 
differences were observed in our sample with regards to methotrexate randomization. 
This study should be understood in the setting of potential limitations. Because 
families were enrolled only after the diagnosis of acute lymphoblastic leukemia, data 
regarding baseline inter-family member dynamics and relationships as well as 
economic/occupational, family building, and housing relocation plans, prior to a child’s 
acute lymphoblastic leukemia diagnosis, are not available. For example, the quality of the 
parents’ marriage prior to the child’s diagnosis was not determined. While the burden of 
a new cancer diagnosis likely has major ramifications for a marital relationship, it is also 
plausible that financial, emotional, and interpersonal strains existed prior to the diagnosis. 
As such, it is impossible to determine whether the child’s diagnosis and treatment of 
acute lymphoblastic leukemia was the impetus for separation, an additional source of 
conflict, or non-contributory. Similarly, we did not ascertain the reason for home 
relocation. This would be helpful in clarifying whether families moved for work, for 
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treatment, to be closer to extended family for psychosocial or financial reasons, or for 
reasons unrelated to the leukemia.  
Participants with missing data at time point 3 reported higher scores on the Peds 
QL nausea subscale at time point 1. While this may be more correlative than causative, it 
would be interesting to further examine whether a child’s physical symptoms affect 
parental participation. It may be plausible that nausea caused a family to either be late or 
re-schedule a clinic appointment hence leading to confusion with regards to 
administration of the survey and a subsequently missed data point.  
Given the dynamic nature of family planning, it is possible that families, who 
decided not to have more children, will choose to have more children upon completion of 
average risk acute lymphoblastic leukemia treatment. As such, analysis of later time 
points is needed to clarify whether changes to family planning were temporary or 
permanent decisions.  
For most participating families, the surveys for all three time points were 
completed by the same primary caregiver. However, at some time points, a caregiver 
other than the one who completed the initial survey was present and completed the study 
survey. The occasional difference in reporter is a potential limitation; nonetheless, the 
majority of survey questions, especially those related to the six study outcomes of interest 
(divorce, moving, loss of employment/opportunities, increased work hours, decreased 
work hours, and changes to family planning), were worded in such a way as to elicit 
reporting of objective, discrete life events, rather than subjective feelings thereby limiting 
inter-reporter variability.  Furthermore, parent self-report was used to limit social 
desirability bias that may occur with an interview format as some parents may not wish to 
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discuss in-person difficulties regarding sensitive topics, such as finances and marital 
satisfaction. 
For a comparison group, we gathered United States Census data for populations 
that were age-matched for our study cohort; however, not all of the potentially 
contributing demographic factors were available in the Census data. As such, our use of 
Census data can only provide a rough comparison group. The impact of including one 
Australian site in our results is limited as this site enrolled only 8 patients. Furthermore, 
we controlled for potential cultural and economic differences by excluding these eight 
participants in our calculations of annual incidences of family life event outcomes, which 
were then subsequently compared to United States Census data. Given that our study 
included thirty United States sites, the results predominantly represent the family 
situation in the United States, and we believe the use of national census data for rough 
comparison is accurate. 
Of the 194 families eligible for study enrollment, 169 chose to participate and 
were enrolled in the study. We recognize that there is a potential selection bias as families 
experiencing the greatest burden may be least inclined to participate in this study and to 
take the time to complete multiple surveys. Follow-up to determine the cause of 
withdrawal is needed. However, the eligible participants who withdrew possessed 
demographic features/characteristics that were no different than those who remained and 
continued in the study.   
A potential confounder is the recession in 2008, which overlapped with our period 
of enrollment and likely influenced the financial stability and choices of participating 
families. It would be relevant to delineate a parent’s reason for not starting a new job to 
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determine whether it was a decision made secondary to his or her child’s cancer diagnosis 
versus due to lack of employment opportunities. Given that such decisions are often 
multi-factorial, it would be difficult to clearly separate the two reasons. For example, a 
parent may have chosen not to take a new job because the opportunity was in a location 
that made it more difficult for the family to access a preferred pediatric oncology 
treatment center. Regardless of the lack of information with respect to parental 
motivation for refusing employment opportunities, our observed frequency of job loss 
was about five-fold higher than national figures, suggesting that the child’s diagnosis of 
leukemia did indeed play some role in the decision process. 
While there have been considerable advances in the treatment of childhood acute 
lymphoblastic leukemia, this study emphasizes the great burdens that the disease places 
on the family in the first year after a child’s diagnosis. The burden may be even greater 
for families of children with other cancers that have lower cure rates and more intensive 
therapy. As such, similar studies in other cancers are needed to fully understand the 
impact of childhood cancer on family functioning. Understanding the impact on the entire 
family is essential as a family’s adaptation impacts a child’s adjustment to cancer (4,37). 
Discussion of anticipated family burdens as well as expected treatment and disease-
related symptoms allows physicians to prepare parents for their role as caretakers.  
In our study, a child’s acute symptoms and parental coping strategies did not 
substantially correlate with any of the six major family life event outcomes. As such, our 
results suggest that more clinically modifiable factors, such as a child’s pain and nausea 
or parental coping strategies, do not contribute to family burden in the first year after 
diagnosis as much as the family’s greater socioeconomic context. Therefore, improved 
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access to financial resources, such as gifts and scholarships from private organizations or 
physician letters requesting medical leave benefits, may be needed, especially in the first 
few months of treatment. As noted by Lansky et al., social workers can only offer 
families resources if they are available (9). While many wonderful organization, such as 
Ronald McDonald House, the Make a Wish Foundation, and Leukemia and Lymphoma 
Society, provide financial assistance, low-cost housing options, and other gifts to patients 
and families, the cost of cancer treatment is still substantial. Thus, it may be necessary for 
new legislation to be considered that would enable greater access to economic resources 
to families with financial need.  
Historically, greater awareness of issues surrounding delivery of healthcare has 
been leveraged to encourage policy change, such as with the Affordable Care Act (ACA). 
For example, in the area of cancer survivorship, the ACA’s provision of no lifetime caps 
on coverage may promote greater access to necessary survivorship screening and care 
(38). With regards to children actively undergoing treatment, the ACA’s policy regarding 
insurance coverage despite pre-existing conditions may allow for more parental 
employment flexibility, enabling parents to switch employment without fear of losing 
coverage for their child. Since the closing of enrollment for our study in 2009, the 
Affordable Care Act has been passed and implemented. It remains to be seen how these 
policy changes will affect our study cohort in the later time points, up to two years after 
completion of therapy. Although the provisions in the ACA are a step forward, there 
remains room for growth in the delivery of comprehensive and affordable cancer care. 
Our findings, as well as results from previous studies, suggest the steepest 
incidence of family burdens occur at diagnosis and the initiation of treatment (8,12). For 
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that reason, social workers and other members of the multidisciplinary oncology team 
should help families anticipate these challenges, access financial and social resources, 
and develop coping strategies soon after diagnosis. Additional studies, with more detailed 
questionnaires that elicit baseline states of parental marriage and employment, are needed 
to elicit the degree to which a child’s new cancer diagnosis impacts dynamic, multi-
factorial decisions, such as parental divorce, increasing work hours, and moving during a 
child’s treatment. Our study is ongoing and will prospectively follow children and their 
families until two years after the end of therapy. Results at later time points will be 
essential to determine the persistence of certain family life outcomes seen in the first year 
after diagnosis. These results will also be valuable in determining the family impact 
through the later stages of acute lymphoblastic leukemia treatment and survivorship.  
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
 
References 
1. Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with 
acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology 
group. J Clin Oncol 2012;30:1663-9. 
2. Kazak AE, Boeving CA, Alderfer MA, Hwang WT, Reilly A. Posttraumatic stress symptoms 
during treatment in parents of children with cancer. J Clin Oncol 2005;23:7405-10. 
3. Kazak AE, Barakat LP, Meeske K, et al. Posttraumatic stress, family functioning, and 
social support in survivors of childhood leukemia and their mothers and fathers. J Consult Clin 
Psychol 1997;65:120-9. 
4. Patterson JM, Holm KE, Gurney JG. The impact of childhood cancer on the family: a 
qualitative analysis of strains, resources, and coping behaviors. Psychooncology 2004;13:390-
407. 
5. Grant S, Carlsen K, Bidstrup PE, et al. Parental separation and pediatric cancer: a Danish 
cohort study. Pediatrics 2012;129:e1187-91. 
6. Syse A, Loge JH, Lyngstad TH. Does childhood cancer affect parental divorce rates? A 
population-based study. J Clin Oncol 2010;28:872-7. 
7. Kaplan DM, Grobstein R, Smith A. Predicting the impact of severe illness in families. 
Health Soc Work 1976;1:71-82. 
8. Bloom BS, Knorr RS, Evans AE. The epidemiology of disease expenses. The costs of caring 
for children with cancer. JAMA 1985;253:2393-7. 
9. Lansky SB, Cairns NU, Clark GM, Lowman J, Miller L, Trueworthy R. Childhood cancer: 
nonmedical costs of the illness. Cancer 1979;43:403-8. 
10. Kalnins IV, Churchill MP, Terry GE. Concurrent stresses in families with a leukemic child. 
J Pediatr Psychol 1980;5:81-92. 
11. Lähteenmäki PM, Sjöblom J, Korhonen T, Salmi TT. The life situation of parents over the 
first year after their child's cancer diagnosis. Acta Paediatr 2004;93:1654-60. 
12. Limburg H, Shaw AK, McBride ML. Impact of childhood cancer on parental employment 
and sources of income: a Canadian pilot study. Pediatr Blood Cancer 2008;51:93-8. 
13. Syse A, Larsen IK, Tretli S. Does cancer in a child affect parents' employment and 
earnings? A population-based study. Cancer Epidemiol 2011;35:298-305. 
14. Lansky SB, Black JL, Cairns NU. Childhood cancer. Medical costs. Cancer 1983;52:762-6. 
15. Heath JA, Lintuuran RM, Rigguto G, Tokatlian N, Tikotlian N, McCarthy M. Childhood 
cancer: its impact and financial costs for Australian families. Pediatr Hematol Oncol 
2006;23:439-48. 
16. Brown RT, Kaslow NJ, Madan-Swain A, Doepke KJ, Sexson SB, Hill LJ. Parental 
psychopathology and children's adjustment to leukemia. J Am Acad Child Adolesc Psychiatry 
1993;32:554-61. 
17. Smith M, Bleyer A, Crist W, Murphy S, Sallan SE. Uniform criteria for childhood acute 
lymphoblastic leukemia risk classification. J Clin Oncol 1996;14:680-1. 
18. Matloub Y, Bostrom BC, Hunger SP, et al. Escalating intravenous methotrexate improves 
event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from 
the Children's Oncology Group. Blood 2011;118:243-51. 
19. Hulley S, Cummings S, Browner W, Grady D, Newman T. Designing Clinical Research. 3rd 
ed: Lippincott Williams & Wilkins; 2012. 
20. McCubbin H, Thompson xA, McCubbin M. Family assessment: Resiliency, Coping and 
Adaptation (Inventories for research and practice). Madison, WI: University of Wisconsin 
Publishers; 1996. 
34 
 
 
 
21. McCubbin H, McCubbin M, Patterson J, Cauble A, Wilson L, Warwick W. CHIP. Coping 
Health Inventory for Parents: An Assessment of Parental Coping Patterns in the Care of the 
Chronically Ill Child. Journal of Marriage and Family 1983;45:359-70. 
22. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: 
reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, 
Multidimensional Fatigue Scale, and Cancer Module. Cancer 2002;94:2090-106. 
23. Marital Status. (Accessed October 25, 2013, at 
http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_11_1Y
R_S1201&prodType=table.) 
24. Ihrke DK. Geographical Mobility: 2008 to 2009. In: Faber CS, ed. Current Population 
Reports. Washington, DC: U.S. Census Bureau; 2011:20-565. 
25. Private Sector Gross Job Gains and Job Losses: 2000 to 2010. 2012. (Accessed October 
20, 2013, at http://www.census.gov/compendia/statab/2012/tables/12s0636.pdf.) 
26. Employment by Industry: 2000 to 2010. 2012. (Accessed October 20, 2013, at 
http://www.census.gov/compendia/statab/2012/tables/12s0619.pdf.) 
27. Fife B, Norton J, Groom G. The family's adaptation to childhood leukemia. Soc Sci Med 
1987;24:159-68. 
28. Schuler D, Bakos M, Zsámbor C, et al. Psychosocial problems in families of a child with 
cancer. Med Pediatr Oncol 1985;13:173-9. 
29. Dahlquist LM, Czyzewski DI, Copeland KG, Jones CL, Taub E, Vaughan JK. Parents of 
children newly diagnosed with cancer: anxiety, coping, and marital distress. J Pediatr Psychol 
1993;18:365-76. 
30. Barbarin OA. Stress, Coping, and Marital Functioning Among Parents of Children with 
Cancer. In: Hughes D, ed. Journal of Marriage and the Family: National Council on Family 
Relations; 1985:473-80. 
31. Miedema B, Easley J, Fortin P, Hamilton R, Mathews M. The economic impact on 
families when a child is diagnosed with cancer. Curr Oncol 2008;15:173-8. 
32. Patistea E, Makrodimitri P, Panteli V. Greek parents' reactions, difficulties and resources 
in childhood leukaemia at the time of diagnosis. Eur J Cancer Care (Engl) 2000;9:86-96. 
33. Lansky SB, Cairns NU, Hassanein R, Wehr J, Lowman JT. Childhood cancer: Parental 
discord and divorce. Pediatrics 1978;62:184-8. 
34. Lavee Y, Mey-Dan M. Patterns of change in marital relationships among parents of 
children with cancer. Health Soc Work 2003;28:255-63. 
35. da Silva FM, Jacob E, Nascimento LC. Impact of childhood cancer on parents' 
relationships: an integrative review. J Nurs Scholarsh 2010;42:250-61. 
36. Van Dongen-Melman JE, De Groot A, Hählen K, Verhulst FC. Impact of childhood 
leukemia on family planning. Pediatr Hematol Oncol 1995;12:117-27. 
37. Varni JW, Katz ER, Colegrove R, Dolgin M. Family functioning predictors of adjustment in 
children with newly diagnosed cancer: a prospective analysis. J Child Psychol Psychiatry 
1996;37:321-8. 
38. McCabe MS, Bhatia S, Oeffinger KC, et al. American Society of Clinical Oncology 
Statement: Achieving High-Quality Cancer Survivorship Care. Journal of Clinical Oncology 
2013;31:631-40. 
 
 
35 
 
 
 
Table 1: Characteristics of participants, eligible nonparticipants, and therapeutic 
study cohort 
 
Participants  
(n = 159) 
Eligible 
nonparticipan
ts  
(n = 35) 
P-
value 
Therapeutic 
AALL0331  
 
P-value 
Age at diagnosis: n (%)   0.13  0.002 
2.0-4.99 years 86 (54%) 24 (69%)  3294 (66%)  
5.0-9.99years 73 (46%) 11 (31%)  1666 (34%)  
Gender: n (%)   0.58  0.63 
Female 76 (48%) 19 (54%)  2299 (46%)  
Male 83 (52%) 16 (46%)  2661 (54%)  
Race/Ethnicity: n (%)   0.01  0.03 
White, non-Hispanic 108 (68%) 16 (46%)  2917 (59%)  
Black, non-Hispanic 11 (7%) 1 (3%)  262 (5%)  
Hispanic 26 (16%) 9 (26%)  1005 (20%)  
Other 14 (9%) 9 (25%)  776 (16%)  
Average maternal age 34     
Marital status: n (%)      
Married  105 (66%)     
Living as married 15 (9%)     
Not married (separated, divorced, 
widowed, never married, refused) 
30 (19%)   
  
Missing 9 (6%)     
Maternal education: n (%)      
Less than college (training 
school, high school grad, some 
HS, grade school) 
92 (58%)   
  
At least some college (some 
college, college grad, post-grad) 
55 (35%)   
  
Missing 12 (7%)     
Family size: n (%)      
2 – 3 individuals 26 (16%)     
4 – 5 individuals 93 (58%)     
6 or more individuals 31 (20%)     
Missing 9 (6%)     
Family income: n (%)      
Less than $50,000 72 (45%)     
$50,000-$79,000 25 (16%)     
$80,000 or more 30 (19%)     
Missing 32 (20%)     
Treatment: n (%)     <0.001 
Standard Consolidation, Standard 
Interim Maintenance 
37 (23%)   198 (15%)  
Standard Consolidation, 
Augmented Interim Maintenance 
42 (26%)   445 (34%) 
 
Intensified Consolidation, 41 (26%)   201 (16%)  
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Standard Interim Maintenance 
Intensified Consolidation, 
Augmented Interim Maintenance 
39 (25%)   446 (35%) 
 
Peds QL: score (SD) 
Pain and Hurt*  
49.4 (25.76) 
    
Nausea**  81.3 (17.24) 
    
CHIP: score (SD) 
CHIP subscale 1: Maintaining 
Family Integration, Cooperation, 
and an Optimistic Definition of 
the Situation  
42.9 (9.37) 
  
  
CHIP subscale 2: Maintaining 
Social Support, Self Esteem, and 
Psychological Stability  
25.6(10.39) 
  
  
CHIP subscale 3: Understanding 
the Health Care Situation through 
Communication with Other 
Parents and  Consultation with 
the Health Care Team   
17.3 (4.90) 
  
  
* Normative Pain and Hurt subscale score is 74.7, and **Nausea subscale normative score is 77.8, based on 
the responses of 333 patients with all types of cancer. Higher scores indicate better functioning.  
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Table 2: Cumulative incidence of major family life events  
Time point* 
Total Number 
Respondents 
Number with 
Outcome 
Frequency of Outcome 
(%) 
Parents divorced or separated among married/living together 
1 120 3 3 
2 110 7 6 
3 106 14 13 
Parents divorced or separated among married 
1 105 3 3 
2 97 5 5 
3 91 9 10 
Parents decreased work hours 
1 151 63 42 
2 148 90 61 
3 144 98 68 
Parents increased work hours 
1 156 11 7 
2 144 18 13 
3 138 25 18 
Declined occupational and/or educational opportunities 
1 154 31 20 
2 144 56 39 
3 144 73 51 
Moved residence 
1 156 14 9 
2 144 26 18 
3 139 38 27 
Changed family planning by deciding not to have more children 
1 157 13 8 
2 146 21 14 
3 138 30 22 
*Time point 1, 2, and 3 are approximately 1, 6, and 12 months after diagnosis. The increases in frequencies 
of outcomes between time points are statistically significant for all events at a significance level of p<0.05, 
except for frequency changes from time point 2 to 3 for divorce/separation, increased work hours, and 
decreased work hours. 
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Table 3: Univariate association of patient and family factors with the six outcomes at time point 3 (12 months after diagnosis) 
 Divorced 
Separated 
OR(95% CI) 
Decreased Work 
Hours 
OR(95% CI) 
Increased 
Work Hours 
OR(95% CI) 
Declined 
Opportunities 
OR(95% CI) 
Relocated Home 
OR(95% CI) 
Changed Family 
Planning 
OR(95% CI)  
Age at diagnosis:  
Pre-school (2-4 years old) vs. School-
age (5-9.99 years old)  
1.47 (0.50-4.28) 0.70 (0.34-1.42) 0.49 (0.20-1.19) 2.48 (1.26-4.86) 1.03 (0.49-2.19) 2.17 (0.91-5.16) 
Race/Ethnicity:  
Other vs. White, non-Hispanic 
2.40 (0.84-6.90) 2.28 (0.99-5.29) 1.25 (0.51-3.12) 1.83 (0.90-3.73) 2.88 (1.33-6.29) 1.14 (0.48-2.70) 
Family Income:  
Less than $50,000 vs.$50,000 or more 
4.33 (0.91-20.1) 0.95 (0.43-2.07) 0.97 (0.36-2.63) 3.21 (1.49-6.94) 1.57(0.65-3.76) 0.80 (0.32-1.98) 
Maternal Education:  
No college vs. At least some college 
4.61 (1.00-21.28) 1.64 (0.78-3.43) 1.25 (0.49-3.19) 2.05 (1.00-4.20) 4.63(1.65-12.99) 1.17 (0.48-2.88) 
Marital Status:  
Other vs. Married or live together 
 0.83 (0.33-2.06) 2.01 (0.73-5.56) 1.66 (0.71-3.88) 0.72 (0.25-2.12) 0.33 (0.07-1.49) 
Family size:  
2-3 vs.4-5 
0.71 (0.14-3.51) 2.13 (0.66-6.90) 1.20 (0.35-4.13) 1.40 (0.56-3.48) 1.61 (0.57-4.57) 3.44(1.17-10.10) 
6 or more vs.4-5 1.05 (0.30-3.64) 0.58 (0.25-1.38) 1.85 (0.68-5.05) 1.94 (0.82-4.61) 1.38 (0.54-3.51) 1.46 (0.49-4.33) 
Pain and Hurt subscale 0.97 (0.95-1.00) 1.00 (0.99-1.01) 1.00 (0.99-1.02) 1.01 (0.99-1.02) 1.00 (0.98-1.01) 1.01 (0.99-1.03) 
Nausea subscale 1.00 (0.97-1.04) 0.98 (0.95-1.00) 1.00 (0.97-1.03) 0.99 (0.97-1.01) 0.97 (0.95-1.00) 1.01 (0.98-1.04) 
Maintaining family integration coping 
behaviors (CHIP subscale 1) 
0.95 (0.90-1.00) 0.96 (0.92-1.01) 0.97 (0.93-1.02) 0.98 (0.94-1.02) 0.99 (0.95-1.04) 0.95 (0.91-1.00) 
Maintaining social support coping 
behaviors (CHIP subscale 2) 
0.99 (0.94-1.05) 0.99 (0.95-1.02) 1.06 (1.01-1.11) 1.00 (0.97-1.03) 1.03 (0.98-1.07) 0.97 (0.93-1.01) 
Understanding the medical situation 
coping behaviors (CHIP subscale 3) 
0.90 (0.82-1.00) 0.99 (0.91-1.06) 0.98 (0.89-1.07) 1.02 (0.95-1.09) 1.03 (0.95-1.11) 0.96 (0.89-1.05) 
Treatment*:  
IC/AIM vs. SC/SIM 0.54 (0.12-2.48) 3.75(1.05-13.34) 0.58(0.18-1.84) 0.74 (0.28-1.98) 1.56 (0.52-4.69) 1.65(0.56-4.89) 
 
SC/AIM vs. SC/SIM 0.48 (0.11-2.18) 0.83 (0.32-2.19) 0.20 (0.05-0.79) 0.34 (0.13-0.89) 1.08 (0.37-3.15) 0.35(0.10-1.31) 
IC/SIM vs. SC/SIM 0.88 (0.23-3.34) 0.66 (0.25-1.74) 0.45 (0.14-1.40) 0.44 (0.17-1.14) 1.16 (0.39-3.40) 0.70(0.22-2.21) 
*SC-standard consolidation; IC-intensified consolidation (additional cyclophosphamide and peg-asparaginase); SIM- standard interim maintenance (oral 
methotrexate); AIM-augmented interim maintenance (escalating intravenous methotrexate) 
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Table 4: Multivariate analyses for the association of patient and family factors with the six outcomes at time point 3 (12 
months after diagnosis) 
 
 
Divorced 
Separated 
OR(95% CI) 
Decreased Work 
Hours 
OR(95% CI) 
Increased Work 
Hours  
OR(95% CI) 
Declined 
Opportunities 
OR(95% CI) 
Relocated 
Home  
OR(95% CI) 
Changed Family 
Planning 
OR(95% CI) 
Age at diagnosis:  
Pre-school (2-4 years old) vs. School-
age (5-9.99 years old) 
  
 
4.21(1.73-10.25)  1.72 (0.63-4.66) 
Race/Ethnicity:  
Other vs. White, non-Hispanic 
  
2.40 (0.93-6.24) 
  
0.71 (0.26- 1.97) 
 
1.93 (0.79-4.74) 
 
Family Income:  
Less than $50,000 vs.$50,000 or 
more 
 
3.16(0.52-19.23) 
 
 
  
4.25(1.50-12.02) 
  
Maternal Education:  
No college vs. At least some college 
 
1.72(0.28-10.64) 
   
1.52 (0.57-4.05) 
 
4.27 (1.43-12.82) 
 
Family size:  
2-3 vs.4-5 
  
1.82(0.52-6.37) 
    
3.62 (1.10- 11.96) 
6 or more vs.4-5  0.44(0.16-1.18)    1.54 (0.44- 5.36) 
Pain and Hurt subscale 0.97(0.95-1.00)      
Nausea subscale  0.98(0.95-1.00)   0.97 (0.94-0.99)  
Maintaining family integration 
coping behaviors (CHIP subscale 1) 
 
1.02(0.93-1.11) 
     
0.95 (0.90- 1.00) 
Maintaining social support coping 
behaviors (CHIP subscale 2) 
   
1.06(1.01-1.12) 
   
Understanding the medical situation 
coping behaviors (CHIP subscale 3) 
 
0.90 (0.75- 1.07) 
     
Treatment*:  
IC/AIM vs. SC/SIM 
  
3.45(0.89-13.30) 
 
0.40(0.10-1.59) 
 
0.84 (0.24-2.86) 
  
1.18 (0.32- 4.35) 
SC/AIM vs. SC/SIM  1.44(0.48-4.26) 0.18(0.04-0.80) 0.30 (0.09-1.02)  0.34 (0.08- 1.42) 
IC/SIM vs. SC/SIM  0.99(0.33-2.93) 0.48(0.14-1.69) 0.25 (0.07-0.87)  0.46 (0.12- 1.81) 
*SC-standard consolidation; IC-intensified consolidation (additional cyclophosphamide and peg-asparaginase); SIM- standard interim maintenance (oral 
methotrexate); AIM-augmented interim maintenance (escalating intravenous methotrexate) 
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Figure 1: Cumulative Incidence of Family Life Events in the First Year of Treatment of Acute Lymphoblastic Leukemia 
 
 
 
 
*Among those married or living together as married prior at diagnosis.  
The increases in frequencies of outcomes between time points are statistically significant for all events at a significance level of 
p<0.05, except for frequency changes from time point 2 to 3 for divorce/separation, increased work hours, and decreased work hours. 
